Drug Changes
Recent Drug Changes
Review recent approvals, biosimilar updates, dosing changes, indications, pronunciation updates, and more.
Popular
Filter
Indication Added
Indication Added
25 changes from the current 90-day window.
Indication Added
View drug
Tecentriq
GENENTECH
Indication Added: Microsatellite instability-high colorectal cancer.
Indication Added
View drug
Tecentriq hybreza
GENENTECH
Indication Added: Microsatellite instability-high colorectal cancer.
Indication Added
View drug
Gazyva
GENENTECH
Indication Added: Frequently relapsing or steroid-dependent childhood-onset idiopathic nephrotic syndrome.
Indication Added
View drug
Kerendia
Bayer HealthCare
Indication Added: Chronic kidney disease associated with type 1 diabetes mellitus.
Indication Added
View drug
Verzenio
Eli Lilly and Company
Indication Added: ER-positive, HER2-negative, ESR1-mutated breast cancer.
Indication Added
View drug
Mounjaro
Eli Lilly and Company
Indication Added: Cardiovascular event risk reduction in type 2 diabetes mellitus.
Indication Added
View drug
Mounjaro
A-S MEDICATION
Indication Added: Cardiovascular event risk reduction in type 2 diabetes mellitus.
Indication Added
View drug
Tregzi hspc component
ORCA BIOSYSTEMS
Indication Added: Prevention of graft-versus-host disease.
Indication Added
View drug
Tevimbra
BEONE MEDICINES
Indication Added: HER2-positive adenocarcinoma of gastroesophageal junction; HER2-positive esophageal adenocarcinoma; HER2-positive gastric adenocarcinoma; PD-L1 positive squamous cell carcinoma of esophagus.
Indication Added
View drug
Ziihera
JAZZ PHARMACEUT
Indication Added: HER2-positive adenocarcinoma of gastroesophageal junction; HER2-positive gastric adenocarcinoma; HER2-positive esophageal adenocarcinoma.
Indication Added
View drug
Tregzi treg component
ORCA BIOSYSTEMS
Indication Added: Prevention of graft-versus-host disease.